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Abstract 
Introduction: Literature data provide little information about protozoa infections and gut microbiota compositional shifts in humans. This 
preliminary study aimed to describe the fecal bacterial community composition of people from Côte d’Ivoire harboring Giardia duodenalis, 
Entamoeba spp., and Blastocystis hominis, in trying to discover possible alterations in their fecal microbiota structure related to the presence 
of such parasites.  
Methodology: Twenty fecal samples were collected from people inhabiting three different localities of Côte d’Ivoire for copromicroscopic 
analysis and molecular identification of G. duodenalis, Entamoeba spp., and B. hominis. Temporal temperature gradient gel electrophoresis 
(TTGE) was used to obtain a fingerprint of the overall bacterial community; quantitative polymerase chain reaction (qPCR) was used to define 
the relative abundances of selected bacterial species/group, and multivariate statistical analyses were employed to correlate all data. 
Results: Cluster analysis revealed a significant separation of TTGE profiles into four clusters (p < 0.0001), with a marked difference for G. 
duodenalis-positive samples in relation to the others (p = 5.4×10-6). Interestingly, qPCR data showed how G. duodenalis-positive samples were 
related to a dysbiotic condition that favors potentially harmful species (such as Escherichia coli), while Entamoeba spp./B. hominis-positive 
subjects were linked to a eubiotic condition, as shown by a significantly higher Faecalibacterium prausnitzii-Escherichia coli ratio. 
Conclusions: This preliminary investigation demonstrates a differential fecal microbiota structure in subjects infected with G. duodenalis or 
Entamoeba spp./B. hominis, paving the way for using further next-generation DNA technologies to better understand host-parasite-bacteria 
interactions, aimed at identifying potential indicators of microbiota changes. 
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Introduction 
The human intestinal microbiota contains a 
complex combination of microorganisms, including 
bacterial and viral taxa [1]. Microbiota is also 
characterized by the eukaryotic component 
encompassing helminths and protists [2,3]. Parasites 
react with the microbial community and with the host, 
greatly impacting the host/gut microbiota balance and 
influencing microbiota protective and 
immunomodulatory functions [1,3,5-8]. Among 
protozoa, Giardia duodenalis (syn. G. intestinalis, G. 
lamblia), Entamoeba histolytica/E. dispar, and 
Blastocystis hominis are common gastrointestinal 
parasites widespread in developing countries, where the 
lack of safe water and sanitation leads to increased 
exposure to infectious agents. It is now well known that 
these protozoa are constantly interacting with the 
intestinal microbiota, but their possible relation to 
imbalances in microbiota composition, termed 
dysbiosis, is still unclear. Giardia infection may trigger 
long-lasting changes in the spatial distribution of 
commensal microorganisms, enhancing bacterial 
invasiveness and inflammatory responses in the gut 
mucosa during the post-clearance phase [9]. Regarding 
E. histolytica, significant alterations of predominant gut 
bacteria and a depletion of some predominant genera 
(e.g., Bacteroides, Eubacterium, Lactobacillus) in the 
gut of infected patients has been described [10]. The 
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hypothesis that Blastocystis might also be linked to 
intestinal flora imbalance has been recently supported 
in a study involving patients with irritable bowel 
syndrome [11]. 
The main purpose of this preliminary study was to 
highlight the relation of G. duodenalis, Entamoeba 
spp., and B. hominis infections with fecal microbiota 
composition in subjects living in southern Côte 
d’Ivoire. In addition, a dysbiosis evaluation was done to 
ascertain the potential alteration of the bacterial 
community associated with the protozoa infections.  
 
Methodology 
Sample collection and management 
Fecal samples were randomly collected in three 
localities in the Grand-Bassam department of southern 
Côte d’Ivoire. The study was based on 20 subjects, 6 
males and 14 females, between 1 and 74 years of age 
(average 21.7 years), with or without symptoms (Table 
1). All other relevant clinical information, including 
having other diseases and antibiotic therapy, were 
noted. One fecal sample was collected in a sterile stool 
container from each patient. After registration, the 
sample was divided into two aliquots. The first aliquot 
was immediately examined for intestinal parasites in 
the Clinical Laboratory of the Don Orione Centre in 
Bonoua by wet mount Lugol’s iodine staining method 
and formol ethyl-acetate concentration technique, and 
analyzed by light microscope. The second aliquot was 
preserved for microbial community analysis by adding 
the Qiagen Allprotect Tissue Reagent (QIAGEN, 
Hilden, Germany), frozen at -20°C, and transported to 
the University of Rome Tor Vergata, Italy, where it was 
kept at -80°C until DNA extraction and molecular 
identification of the parasites. The microbial 
community analysis was conducted at the Sapienza 
University of Rome, Italy. Informed consent was 
obtained from all individual participants included in the 
study; for minors, informed consent was obtained from 
their guardians. All procedures performed in this study 
involving human participants were approved by the 
medical committee of the Don Orione Centre and were 
in accordance with the 1964 Helsinki Declaration and 
its later amendments. 
 
Fecal DNA extraction 
Total DNA was extracted by QIAmp Stool Mini Kit 
(QIAGEN, Hilden, Germany). The manufacturer’s 
protocol was modified by incubating samples with 
proteinase K overnight at 56°C, followed by incubating 
for 4 hours at 37°C with 2 mg/mL (final concentration) 
of lysozyme (Sigma-Aldrich, St. Louis, USA). Eluted 
DNA concentration was quantified by an Eppendorf 
spectrophotometer (BioPhotometer, Eppendorf, 
Hamburg, Germany) at 260 nm, and its quality was 
checked through the 260/280 nm ratio and 1% agarose 
gel electrophoresis. 
 
Table 1. Patients’ characteristics and intestinal protozoa detected  
Subject 
Sampling 
area 
Age 
(years) 
Sex Symptoms of infection 
Protozoa HAC 
clustera G. duodenalis Entamoeba spp. B. hominis 
M1 Bonoua 8 F Abdominal pains Negative Negative + B+ 
M2 Bonoua 21 F Abdominal pains + Negative + G+ 
M3 Bonoua 74 M Asymptomatic Negative E. hartmanni + E/B+ 
M4 Bonoua 5 F Frequent abdominal pains + Negative Negative G+ 
M5 Kimoukro 8 F Frequent abdominal pains + Negative + G+ 
M6 Kimoukro 6 M Frequent abdominal pains + E. hartmanni + All 
M7 Kimoukro 10 F Frequent abdominal pains + E. coli + All 
M8 Bonoua 5 F Frequent abdominal pains + E. dispar Negative G+ 
M9 Bonoua 3 M Asymptomatic + Negative + G+ 
M10 Bonoua 1 F Fever Negative Negative Negative NaN 
M11 Bonoua 9 M Asymptomatic Negative Negative Negative NaN 
M12 Bonoua 40 F Asymptomatic Negative Negative + B+ 
M13 Bonoua 30 M Asymptomatic Negative Negative Negative NaN 
M14 Assouindé 12 F Asymptomatic + E. coli + All 
M15 Assouindé 12 M Asymptomatic Negative E. hartmanni + E/B+ 
M17 Bonoua 50 F Asymptomatic + E. hartmanni + All 
M18 Bonoua 41 F Asymptomatic Negative Negative + B+ 
M19 Bonoua 67 F Asymptomatic Negative Negative Negative NaN 
M20 Bonoua 9 F Asymptomatic + Negative + G+ 
M21 Bonoua 24 F Asymptomatic Negative Negative + B+ 
a Cluster belonging after hierarchical ascendant clusterization analysis on temporal temperature gradient gel electrophoresis profiles. 
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Parasite identification 
Molecular identification of G. duodenalis, 
Entamoeba spp., and B. hominis was done by end-point 
PCR and sequence analysis of the SSU rDNA region. 
For G. duodenalis, a conventional nested PCR was 
performed as described [12]; B. hominis was detected 
by nested-PCR analysis for accurate subtyping [13,14]. 
Finally, the identification of Entamoeba spp. was done 
as previously reported [15]. All PCRs were carried out 
in a 25 μL volume containing 12.5 μL of PCR master 
mix 2X (Promega Italia, Milan, Italy), 100–200 ng of 
template DNA, and 0.6 mM of each primer. PCR 
products were visualized by electrophoresis on 1% 
agarose gel stained by SYBR Safe DNA gel stain 
(Invitrogen, Life Technologies, Monza, Italy). 
Amplicons were purified using the mi-PCR Purification 
Kit (Metabion International AG, Planneg, Germany), 
sequenced by the Bio-Fab Research (Rome, Italy). 
Species identification was determined by comparing the 
obtained sequences in GenBank database by using the 
standard nucleotide BLAST search. 
 
PCR amplification of bacterial 16S rDNA gene and 
TTGE analysis 
In order to amplify the V6–V8 region of bacterial 
16S rDNA, PCR reactions including the universal 
primers GCclamp-U968 and L1401 (Bio-Fab Research, 
Rome, Italy) were used, and 500 ng of DNA of PCR 
product from each sample was used to perform the 
subsequent TTGE experiments, as previously described 
[16]. 
 
Quantitative PCR (qPCR) 
Quantitative analysis of the fecal microbiota 
composition was determined with (qPCR) using SYBR 
Green PCR Master Mix (Applied Biosystems, 
Carlsbad, USA). Each PCR reaction was carried out in 
a final volume of 2 5μL containing 12.5 μL Mix 
(SensiMixTM SYBR Hi-ROX Kit, Bioline, London, 
UK), 1.25 μL of primers (forward and reverse), 2.5 μL 
of BSA (bovine serum albumin), and 2 μL of template 
DNA (approximately 100 ng). PCR amplification was 
performed in 40 cycles using the following conditions: 
95°C for 10 minutes, then 40 cycles of 95°C for 10 
seconds, annealing temperature as in Table 2 for 20 
seconds, and 72°C for 27 seconds. Species-specific 
Table 2. Primers used in this study for SYBR Green qPCR reactions 
Species Primers Sequence 
Annealing 
temperature 
(°C) 
Amplified 
fragment 
(bp) 
Number 
of 16S 
rDNA 
operons 
Reference 
Bacteroides fragilis 
B_fra_F GAAAGCATTAAGTATTCCACCTG 
56 176 6 [17] 
B_fra_R CGGTGATTGGTCACTGACA 
Peptostreptococcus 
productus 
P_prod_F GGTGGCAAAGCCATTCGGT 
56.5 182 1 [17] 
P_prod_R GTTACGGGACGGTCAGAG 
Enterococcus spp. 
E_spp_F CCCTTAATTGTTAGTTGCCATCATT 
56.5 144 4 [18] 
E_spp_R ACTCGTTGTACTTCCCATTGT 
Faecalibacterium 
prausnitzii 
F_prau_F CCCTTCAGTGCCGCAGT 
54.5 158 1 [19] 
F_prau_R GTCGCAGGATGTCAAGAC 
Clostridium leptum group 
C_leptum_group_F GTTGACAAAACGGAGGAAGG 
56 244 2 [20] 
C_leptum_group_R GACGGGCGGTGTGTACAA 
Clostridium coccoides 
group 
C_coccoides_group_F ACTCCTACGGGAGGCAGC 
60 139 3 [20] 
C_coccoides_group_R GCTTCTTAGTCAGGTACCGTCAT 
Lactobacillus/Enterococcus 
group 
Lac_Enter_F AGCAGTAGGGAATCTTCCA 
53 341 7 [20] 
Lac_Enter_R CACCGCTACACATGGAG 
Bacteroides group 
Bact_group_F GGTTCTGAGAGGAGGTCCC 
59.5 64 6 [20] 
Bact_group_R GCTGCCTCCCGTAGGAGT 
Prevotella group 
Prevo_group_F CAGCAGCCGCGGTAATA 
54 309 6 [20] 
Prevo_group_R GGCATCCATCGTTTACCGT 
Escherichia coli 
E_coli_F CATGCCGCGTGTATGAAGAA 
56.5 340 7 [18] 
E_coli_R CGGGTAACGTCAATGAGCAAA 
Bifidobacterium group 
Bifido_group_F CTCCTGGAAACGGGTGGT 
57.5 204 4 [20] 
Bifido_group_R GCTGCCTCCCGTAGGAGT 
Eubacterial universal 
primers 
Tot_bact_F ACTCCTACGGGAGGCAGCAGT 61 172 - [20] 
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primers used, chosen from literature, are reported in 
Table 2 [17-20]. In order to ensure a suitable inter-
species data normalization and interpretation, a 
correction for number of 16S rRNA operons was 
conducted and extrapolated from PATRIC 
(Pathosystems Resource Integration Center) website 
(https://www.patricbrc.org) (Table 2). Standard curves 
for each bacterial species/group were done using a 
range of 109–1010 copies of the plasmid (pUC57) 
containing one copy of the target [21]. The qPCR runs 
were analyzed using the 7300 System SDS Software 
(Applied Biosystems, Foster City, USA), and results 
expressed followed the minimum information for 
publication of quantitative real-time PCR experiments 
(MIQE) guidelines [22,23]. 
 
Statistical analysis 
TTGE profiles were analyzed using Totallab 1D 
software (Totallab, Newcastle upon Tyne, UK), while 
Prism 5 (Graph Pad, LaJolla, USA) and SPSS (SPSS, 
Chicago, USA) statistical software were used to analyze 
qPCR data and to perform Pearson’s correlation. The 
Mann-Whitney U test by Prism 5 was used for 
comparing qPCR results, and a p value ≤ 0.05 was 
considered significant. Orthogonal projection onto 
latent structure (OPLS-DA) analysis was performed 
with SIMCA-P+ software (Umetrics, Umeå, Sweden). 
 
Results 
Parasites prevalence 
No helminth infections were detected by 
microscopic examination. Overall, 16 of 20 subjects 
were positive for intestinal protozoa. Microscopic and 
molecular analysis allowed identification of Giardia 
duodenalis (n = 10), Blastocystis hominis (n = 14), 
Entamoeba coli (n = 2), E. dispar (n = 1), and E. 
hartmanni (n =3). E. histolytica was not detected. 
Among 16 patients who resulted positive for parasites, 
multiple infections were detected in 11 subjects: B. 
hominis plus G. duodenalis (n = 4), B. hominis plus E. 
hartmanni (n = 2), E. dispar plus G. duodenalis (n = 1), 
and four patients were infected with three parasite 
species (Table 1). 
 
Bacterial microbiota characterization 
Based on a hierarchical ascendant clusterization 
(HAC) analysis, TTGE profiles clustered into four 
different groups: G+ (G. duodenalis positive); E/B+ 
(Entamoeba spp. and Blastocystis hominis positive); 
NaN (negative for protozoa); and All (positive for all 
three parasites) (Figure 1). As shown in the 
dendrogram, the separation into four main clusters was 
highly significant (χ2 = 52.86, p < 0.0001). G+ fecal 
profiles were significantly different compared to the 
other three clusters, as assessed by orthogonal 
projection onto latent structure (OPLS-DA) analysis 
(Fisher’s p = 5.4×10-6). 
 
Quantitative PCR of selected bacterial species or 
groups 
For each subject enrolled, a quantitative 
representation of the relative abundance of the bacterial 
species is reported (Figure 2). With respect to the NaN 
group, G+ significantly increased the mean sum of the 
relative abundances as a whole (18.2% ± 5.0% versus 
4.8% ± 1.9%, p = 0.019), while a similar increase was 
Figure 1. Temporal temperature gradient gel electrophoresis 
profiles dendrogram based on fecal samples of subjects from 
Côte d’Ivoire grouped by means of Euclidean dissimilarity and 
agglomeration method of Ward. 
G+: G. duodenalis; All: all three parasites; NaN: none of the parasites; 
E/B+: Entamoeba spp. and B. hominis. 
Figure 2. Relative abundance (%) of fecal bacteria 
species/groups (y axis) reported as the percentage on overall total 
bacteria. Samples were grouped on x axis (NaN, G+, E/B+, All). 
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observed for the E/B+ group, although to a lesser extent 
(10.7% ± 1.7%, p = 0.032). Even if a slight increasing 
trend for E. coli levels in the G+ group was observed in 
the NaN group, it was not significant (p = 0.381), while 
the increase of the Bifidobacterium group in G+ was 
statistically significant (p = 0.047). No differences in 
bacterial/group-relative abundances were observed in 
E/B+ samples with respect to NaN. 
 
Dysbiosis evaluation 
The ratio between the relative abundances of F. 
prausnitzii (a beneficial species) and E. coli (a 
potentially harmful species), called the F/E ratio, was 
used as a dysbiosis index [24,25]. A significant 
difference in F/E ratio was observed in the E/B+ group 
of subjects with respect to NaN (4.02 ± 2.02 versus 0.26 
± 0.19, p = 0.032). No statistical difference in F/E ratio 
was shown by G+ subjects with respect to NaN (p = 
0.129), meaning that, even if a substantial difference 
was found in G+ fecal microbiota composition, an 
alleged dysbiosis could not be revealed by F/E ratio. 
In order to determine putative correlations among 
the different levels of the selected bacterial 
species/groups, Pearson’s correlation index was 
computed within G+ (panel A) and E/B+ (panel B) 
classes for all qPCR data (Figure 3). Within G+ 
subjects, a positive correlation was found among E. coli 
and Enterococcus spp. (Pearson’s correlation 
coefficient = 0.996). Regarding the E/B+ subjects, 
positive correlations were found among the 
Bifidobacterium and B. fragilis group (Pearson’s 
correlation coefficient = 0.966), and among the 
Prevotella and Bacteroides group (Pearson’s 
correlation coefficient = 0.882), while a negative 
correlation was found among the Bifidobacterium 
group and Bacteroides group (Pearson’s correlation 
coefficient = -0.898). 
 
Discussion 
Few data are available on the gut microbiota 
composition in subjects from sub-Saharan Africa 
[19,26]. Moreover, to the best of our knowledge, only a 
recent study examined Blastocystis spp. prevalence and 
gut microbiota structure in a shotgun metagenomic 
dataset of human fecal samples [27], but no subjects 
from sub-Saharan Africa were involved. 
The present pilot study aimed to shed light on 
possible differences in the fecal microbiota of 20 
subjects living in Côte d’Ivoire associated with the 
presence or absence of Giardia duodenalis, Entamoeba 
spp., and Blastocystis hominis. Upon HAC analysis, 
fecal TTGE profiles were significantly grouped into 
four clusters based on the presence of parasites: Giardia 
positive (G+), Entamoeba spp. and Blastocystis 
positive (E/B+), positive for all three parasites (All), 
and negative for any parasite (NaN). From these data, a 
Figure 3. Correlation between fecal bacterial species. The graph 
on the dot matrix of dispersion refers to the bacteria fecal species 
or groups selected, within G+ (panel A), or within E/B+ (panel 
B). Black squares define significant correlation (p ≤ 0.05) found 
with a correlation coefficient of Pearson. Bar plots of diagonal 
define the distribution of data within each bacteria 
species/groups. 
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noticeable separation of G+ subjects from the others 
seems to be evident (Figure 1). These results could 
indicate that the microbial communities are differently 
shaped in the presence of specific parasites, and that G. 
duodenalis could reflect a particular behavior in the 
fecal microbiota ecology during gut colonization. In 
addition, in G+ subjects, a positive correlation among 
Escherichia coli versus Enterococcus spp. (Figure 3, 
panel A) was observed together with a significant 
increase (p < 0.05) of bifidobacteria; also, a trend of 
increase of the species Escherichia coli was evidenced 
when they were compared with NaN group (Figure 3, 
panel A). It could be argued that G. duodenalis might 
favor facultative anaerobic and potentially pathogenic 
species, such as E. coli and Enterococcus spp. The 
increase of bifidobacteria in G+ subjects could 
represent the microbiota attempt to respond to the 
inflammation induced by G. duodenalis. It is known 
that bifidobacteria might exert a variety of beneficial 
health effects, including modulation of local and 
systemic immune responses [28,29]. Additionally, 
Bifidobacterium strains may discourage the growth of 
some Gram-negative diarrheagenic bacteria from 
adults, as evidenced also in infants [29]. 
In E/B+ subjects, a significant positive correlation 
was found among Bifidobacterium versus B. fragilis, 
and Prevotella versus Bacteroides, and a negative 
correlation was found between Bifidobacterium versus 
Bacteroides (Figure 3, panel B). The genera Prevotella 
and Bacteroides belong to the phylum Bacteroidetes, 
and are all species/genera considered beneficial. The 
results observed in E/B+ subjects seem to indicate that 
the presence of the parasites Entamoeba spp. and B. 
hominis would alter the microbiota balance towards a 
eubiotic condition, as shown by the high F/E ratio in 
respect to NaN. This finding is in contrast to that found 
for G. duodenalis, and the comparison of E. coli relative 
abundances, higher in G+ and lower in E/B+ (Figure 3), 
seems to reinforce such a hypothesis. 
 
Conclusions 
In conclusion these preliminary baseline data 
encourage us to pursue further research using next-
generation DNA technologies for a prospective 
extension of the potential role of micro-eukaryotes in 
microbiota composition [30]. Gut microbiota studies in 
endemic countries could represent a useful approach to 
understand the complex scenario during multiple 
parasitic infections and to identify potential indicators 
of microbiota changes [11] and tropical enteropathy 
[31]. Finally, these studies could also provide 
potentially critical information for protozoa-related 
dysbiosis in asymptomatic subjects that could be 
involved in low-grade systemic inflammation of non-
communicable chronic degenerative diseases such as 
obesity, diabetes, and atherosclerosis, all with 
increasing prevalence in developing countries. 
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